³ÉÈË´óƬ Vice-Principal ResearchPatent
May 6, 2025: Canadian Patent No. 3,013,376 "Method and Apparatus for Acoustic and Tactile Presentation of Chemical Spectrum Data"
May 06, 2025
³ÉÈË´óƬ Partnerships and Innovation is pleased to report the issuance of Canadian Patent No. 3,013,376
May 6, 2025: Canadian Patent No. 3,022,981 "Hippo Pathway Bioluminescent Biosensor"
May 06, 2025
³ÉÈË´óƬ Partnerships and Innovation is pleased to report the issuance of Canadian Patent No. 3,022,981
April 29, 2025: U.S. Patent No. 12,286,558 "UV-Curable Anti-Smudge and Anti-Graffiti Compositions"
Apr 29, 2025
Queen’s Partnerships and Innovation is pleased to report the issuance of U.S. Patent No. 12,286,558
Glaucoma monitoring device receives CIHR commercialization funding
Apr 28, 2025
Contact lens-based device from Queen’s startup LenSense aims to transform glaucoma management and improve patient outcomes.
April 22, 2025: U.S. Patent No. 12,282,001 "Systems, Devices, and Methods for Electrochemical Water Analysis"
Apr 22, 2025
Queen’s Partnerships and Innovation is pleased to report the issuance of U.S. Patent No. 12,282,001
April 15, 2025: U.S. Patent No. 12,278,555 "Variable Gain Modulation Methods and Controllers for AC-DC Converter with Power Factor Correction"
Apr 15, 2025
Queen’s Partnerships and Innovation is pleased to report the issuance of U.S. Patent No. 12,278,555
Cntrl+ Inc. receives clearance from the US Food and Drug Administration
Apr 03, 2025
After an arduous journey, Cornwall-based Cntrl+ Inc. officially received clearance from the United States Food and Drug Administration (US FDA) for its reusable female bladder support in December 2024.
March 25, 2025: Canadian Patent No. 3,081,724 "High Output Current Transconductance Amplifier"
Mar 25, 2025
³ÉÈË´óƬ Partnerships and Innovation is pleased to report the issuance of Canadian Patent No. 3,081,724
March 11, 2025: U.S. Patent No. 12,245,816 "Intraocular Pressure Monitoring Contact Lens"
Mar 11, 2025
Queen’s Partnerships and Innovation is pleased to report the issuance of U.S. Patent No. 12,245,816
March 11, 2025: U.S. Patent No. 12,245,817 "Non-Invasive Intraocular Pressure Monitor"
Mar 11, 2025
Queen’s Partnerships and Innovation is pleased to report the issuance of U.S. Patent No. 12,245,816
March 4, 2025: U.S. Patent No. 12,239,639 "Cytotoxic Actin-Targeting Compounds"
Mar 04, 2025
Queen’s Partnerships and Innovation is pleased to report the issuance of U.S. Patent No. 12,239,639
October 22, 2024: U.S. Patent No. 12,123,894 "Apparatus and Method for Measuring Velocity Perturbations in a Fluid"
Oct 22, 2024
Queen’s Partnerships and Innovation is pleased to report the issuance of U.S. Patent No. 12,123,894